Related Experiment Video
Updated: Aug 18, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
[Deep venous thrombosis and pulmonary embolism. Prophylaxis and therapy]
Jan Beyer1, Sebastian Schellong
1Bereich Angiologie, Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden.
Abstract:
Venous thromboembolism is a common cause of morbidity and mortality with an estimated annual incidence of 1:1,000. Several patient groups at risk can be differentiated, according to the presence of endogenous factors (such as hereditary thrombophilic disorders), but much more by exogenous factors (underlying disease). This results in risk-adapted recommendations for prophylaxis and therapy, which will be discussed in the following overview.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis I: Introduction